BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lee HJ, Kim JI, Lee JS, Jun EJ, Oh JH, Cheung DY, Chung WC, Kim BW, Kim SS. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies. World J Gastroenterol 2015; 21(1): 351-359 [PMID: 25574111 DOI: 10.3748/wjg.v21.i1.351]
URL: https://www.wjgnet.com/1007-9327/full/v21/i1/351.htm
Number Citing Articles
1
Sotirios D. Georgopoulos, Elias Xirouchakis, Beatrice Martinez-Gonzales, Evanthia Zampeli, Elias Grivas, Charikleia Spiliadi, Maria Sotiropoulou, Kalliopi Petraki, Kostantinos Zografos, Fotini Laoudi, Dionysios Sgouras, Andreas Mentis, Panagiotis Kasapidis, Spyros Michopoulos. Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance areaEuropean Journal of Internal Medicine 2016; 32: 84 doi: 10.1016/j.ejim.2016.04.011
2
Lien-Chieh Lin, Tzu-Herng Hsu, Kuang-Wei Huang, Ka-Wai Tam. Nonbismuth concomitant quadruple therapy for <i>Helicobacter pylori</i> eradication in Chinese regions: A meta-analysis of randomized controlled trialsWorld Journal of Gastroenterology 2016; 22(23): 5445-5453 doi: 10.3748/wjg.v22.i23.5445
3
Youhua Wang, Rulin Zhao, Ben Wang, Qiaoyun Zhao, Zhen Li, Liya Zhu-ge, Wenzhu Yin, Yong Xie. Sequential versus concomitant therapy for treatment of Helicobacter pylori infection: an updated systematic review and meta-analysisEuropean Journal of Clinical Pharmacology 2018; 74(1): 1 doi: 10.1007/s00228-017-2347-7
4
Salamata Diallo, Marie Louise Bassène, Marieme Polele Fall, Alia Issa, Mame Aisse Thioubou. Evaluation of Three Helicobacter pylori Eradication Protocols in a Digestive Endoscopy Center in DakarOpen Journal of Gastroenterology 2021; 11(11): 244 doi: 10.4236/ojgas.2021.1111025
5
Beom Jin Kim, Hyun-Soo Kim, Hyun Joo Song, Il-Kwun Chung, Gwang Ha Kim, Byung-Wook Kim, Ki-Nam Shim, Seong Woo Jeon, Yun Jin Jung, Chang-Hun Yang, Ji Hyun Kim, Tae Ho Kim, Sang Gyun Kim, Woon Geon Shin, Sun Moon Kim, Sok Won Han, Jun Haeng Lee, Kyung Ho Kim, Sue K. Park, Byung-Joo Park, Joongyub Lee, Jae G. Kim. Online Registry for Nationwide Database of Current Trend ofHelicobacter pyloriEradication in Korea: Interim AnalysisJournal of Korean Medical Science 2016; 31(8): 1246 doi: 10.3346/jkms.2016.31.8.1246
6
Hyun Joo Song, Ki-Nam Shim, Byung-Wook Kim. Web Survey of Society Members' Recognition of Guidelines for the Diagnosis and Treatment ofHelicobacter pyloriInfection in Korea, 2013 Revised EditionThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(2): 95 doi: 10.7704/kjhugr.2015.15.2.95
7
Natsuda Aumpan, Varocha Mahachai, Ratha‐korn Vilaichone. Management of Helicobacter pylori infectionJGH Open 2023; 7(1): 3 doi: 10.1002/jgh3.12843
8
Olga P Nyssen, Adrian G McNicholl, Francis Megraud, Vincenzo Savarino, Giuseppina Oderda, Carlo A Fallone, Lori Fischbach, Franco Bazzoli, Javier P Gisbert. Sequential versus standard triple first-line therapy forHelicobacter pylorieradicationCochrane Database of Systematic Reviews 2016; 2016(6) doi: 10.1002/14651858.CD009034.pub2
9
Huimei Xu, Wancong Wang, Xueni Ma, Rukun Feng, Yujing Su, Long Cheng, Yifan Yang, Dekui Zhang. Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysisEuropean Journal of Gastroenterology & Hepatology 2021; 33(6): 775 doi: 10.1097/MEG.0000000000001835
10
Jong Kyu Park. Can Hybrid Therapy Be an Alternative to the First-line Regimen for Helicobacter pylori Infection?The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020; 20(4): 257 doi: 10.7704/kjhugr.2020.0051
11
Joonhwan Kim, Kyungwon Kim, Jun Soo Lee, Su Young Kim, Kyung Oh Kim, Yoon Jae Kim, Kwang an Kwon, Dong Kyun Park, Jun-Won Chung. The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) RegimenThe Korean Journal of Gastroenterology 2018; 71(4): 204 doi: 10.4166/kjg.2018.71.4.204
12
Mei-Jyh Chen, Chien-Chuan Chen, Yen-Nien Chen, Chieh-Chang Chen, Yu-Jen Fang, Jaw-Town Lin, Ming-Shiang Wu, Jyh-Ming Liou. Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori InfectionAmerican Journal of Gastroenterology 2018; 113(10): 1444 doi: 10.1038/s41395-018-0217-2
13
Kh. R. Aslanova. SOME RESULTS AND PROSPECTS OF THE STUDY OF HELICOBACTER PYLORI INFECTIONBulletin of Problems Biology and Medicine 2019; 1(2): 111 doi: 10.29254/2077-4214-2019-1-2-149-111-114
14
Seung Joo Kang, Hye-Kyung Jung, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Eradication Rates of Clarithromycin Triple Therapy in Korea: A Systematic Review and Meta-analysisThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2021; 21(1): 35 doi: 10.7704/kjhugr.2020.0056
15
Seung Young Kim, Sang Woo Lee, Jung Wan Choe, Sung Woo Jung, Jong Jin Hyun, Young Kul Jung, Ja Seol Koo, Hyung Joon Yim. Helicobacter pylori eradication rates of concomitant and sequential therapies in KoreaHelicobacter 2017; 22(6) doi: 10.1111/hel.12441
16
Jae Yong Park, Jae Gyu Kim. NewHelicobacter pyloriEradication TherapiesThe Korean Journal of Gastroenterology 2018; 72(5): 237 doi: 10.4166/kjg.2018.72.5.237
17
ROQUE SÁENZ F.. “HELICOBACTER PYLORI, HOY”. UNA HISTORIA DE 30 AÑOS…Revista Médica Clínica Las Condes 2015; 26(5): 572 doi: 10.1016/j.rmclc.2015.09.004
18
Javier Alcedo, Marta Gracia, Paula García-Cámara, Carmen Palacín, Sonia Gallego, Cristina Jimeno-Ayllon, Santiago Frago, Isabel Aured, Lara Luzón. Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapyGastroenterología y Hepatología (English Edition) 2020; 43(6): 301 doi: 10.1016/j.gastre.2019.12.002
19
Bo Li, Xiaoqian Lan, Li Wang, Jiani Zhao, Jingli Ding, Hao Ding, Jun Lei, Yiping Wei, Wenxiong Zhang. Proton-pump inhibitor and amoxicillin-based triple therapy containing clarithromycin versus metronidazole for Helicobacter pylori: A meta-analysisMicrobial Pathogenesis 2020; 142: 104075 doi: 10.1016/j.micpath.2020.104075
20
Su Young Kim, Duck Joo Choi, Jun-Won Chung. Antibiotic treatment for <italic>Helicobacter pylori</italic>: Is the end coming?World Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 183-198 doi: 10.4292/wjgpt.v6.i4.183
21
Masaki Murata, Mitsushige Sugimoto, Hitomi Mizuno, Takeshi Kanno, Kiichi Satoh. Clarithromycin Versus Metronidazole in First-Line Helicobacter Pylori Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-AnalysisJournal of Clinical Medicine 2020; 9(2): 543 doi: 10.3390/jcm9020543
22
Yeon‐Ji Kim, Woo Chul Chung, Dae Bum Kim. Efficacy of bismuth added to standard triple therapy as the first‐line eradication regimen for Helicobacter pylori infectionHelicobacter 2021; 26(3) doi: 10.1111/hel.12792
23
Chung Hyun Tae, Ki-Nam Shim. Current Strategies for Eradication ofHelicobacter pyloriin KoreaThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(4): 222 doi: 10.7704/kjhugr.2015.15.4.222
24
Moon Won Lee, Gwang Ha Kim, Sung Yong Han, Young Joo Park, Hye Kyung Jeon, Bong Eun Lee, Geun Am Song. First-lineHelicobacter pyloriEradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective StudyThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2018; 18(2): 120 doi: 10.7704/kjhugr.2018.18.2.120
25
Joon Sung Kim. The Optimal Second-line Rescue Therapy after Failure of Non-bismuth Quadruple TreatmentsThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(2): 145 doi: 10.7704/kjhugr.2015.15.2.145
26
Didem Şen Karaman, Utku Kürşat Ercan, Emel Bakay, Nermin Topaloğlu, Jessica M. Rosenholm. Evolving Technologies and Strategies for Combating Antibacterial Resistance in the Advent of the Postantibiotic EraAdvanced Functional Materials 2020; 30(15) doi: 10.1002/adfm.201908783
27
Da Wit Shin, Dae Young Cheung, Ji Hee Song, Kyungseok Choi, Jihye Lim, Han Hee Lee, Jin Il Kim, Soo-Heon Park. The benefit of the bismuth add-on to the 2-week clarithromycin-based triple regimen for Helicobacter pylori eradication: a propensity score-matched retrospective studyGut Pathogens 2023; 15(1) doi: 10.1186/s13099-023-00539-y
28
Jun-Hyung Cho, So-Young Jin. Current guidelines for <i>Helicobacter pylori </i>treatment in East Asia 2022: Differences among China, Japan, and South KoreaWorld Journal of Clinical Cases 2022; 10(19): 6349-6359 doi: 10.12998/wjcc.v10.i19.6349
29
Zohreh Bari, Hafez Fakheri, Tarang Taghvaei, Mohammad Yaghoobi. A Comparison between 10-day and 12-day Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical TrialMiddle East Journal of Digestive Diseases 2020; 12(2): 106 doi: 10.34172/mejdd.2020.169
30
Sung Min Jung, Dae Young Cheung, Jin Il Kim, Il Kim, Hyeonjin Seong. Comparing the Efficacy of Concomitant Therapy with Sequential Therapy as the First-Line Therapy ofHelicobacter pyloriEradicationGastroenterology Research and Practice 2016; 2016: 1 doi: 10.1155/2016/1293649
31
Keliang Wang, Dandi Lou, Wei Dai, Rongrong Fu, Zhenhua Ma. Comparison of sequential therapy with concomitant therapy in first-line treatment of Helicobacter pylori: an updated meta-analysis Journal of Medical Microbiology 2022; 71(1) doi: 10.1099/jmm.0.001490
32
Olga P. Nyssen, Belén Martínez, Francis Mégraud, Vincenzo Savarino, Carlo A. Fallone, Franco Bazzoli, Javier P. Gisbert. Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An UpdateAntibiotics 2024; 13(2): 136 doi: 10.3390/antibiotics13020136
33
Endalew Gebeyehu, Desalegn Nigatu, Ephrem Engidawork, Yan Li. Self-reported adverse drug effects and associated factors among H. pylori infected patients on standard triple therapy: Prospective follow up studyPLOS ONE 2019; 14(11): e0225585 doi: 10.1371/journal.pone.0225585
34
Kazunori Nagashima, Keiichi Tominaga, Koh Fukushi, Akira Kanamori, Takako Sasai, Hideyuki Hiraishi. Recent trends in the occurrence of bleeding gastric and duodenal ulcers under the Japanese evidence‐based clinical practice guideline for peptic ulcer diseaseJGH Open 2018; 2(6): 255 doi: 10.1002/jgh3.12078
35
Soo Yeon Choi, Na Rae Lim, Woo Chul Chung. Tailored Therapy Using Bismuth Add-on Standard Triple Therapy vs. Concomitant Therapy: A First-line Regimen for Helicobacter pylori InfectionThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2023; 23(2): 118 doi: 10.7704/kjhugr.2022.0058
36
Javier Alcedo, Marta Gracia, Paula García-Cámara, Carmen Palacín, Sonia Gallego, Cristina Jimeno-Ayllon, Santiago Frago, Isabel Aured, Lara Luzón. Prospective comparative study between two first-line regimens for Helicobacter pylori eradication: Non-bismuth quadruple versus bismuth quadruple therapyGastroenterología y Hepatología 2020; 43(6): 301 doi: 10.1016/j.gastrohep.2019.12.002
37
Jong Yeul Lee, Ji Yong Ahn, Il Ju Choi. Historical Perspective ofHelicobacter pyloriTreatment in KoreaThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(4): 211 doi: 10.7704/kjhugr.2015.15.4.211
38
Sanjeev Kumar Jha, Manish K. Mishra, Kuldeep Saharawat, Praveen Jha, Shubham Purkayastha, Ravish Ranjan. Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trialIndian Journal of Gastroenterology 2019; 38(4): 325 doi: 10.1007/s12664-019-00949-4
39
Ru-Jia Li, Yuan-Yuan Dai, Chun Qin, Xiao-Hua Li, Yan-Chun Qin, Yong Pan, Yong-Yi Huang, Zan-Song Huang, Yan-Qiang Huang. Treatment strategies and preventive methods for drug-resistant <i>Helicobacter pylori</i> infectionWorld Journal of Meta-Analysis 2020; 8(2): 98-108 doi: 10.13105/wjma.v8.i2.98
40
Yoon Suk Jung, Chan Hyuk Park, Jung Ho Park, Eunwoo Nam, Hang Lak Lee. Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta‐analysisHelicobacter 2017; 22(4) doi: 10.1111/hel.12389
41
Hyun Jin Bae, Joon Sung Kim, Byung-Wook Kim, Yun Jung Nam. Concomitant or Sequential Therapy as the First-line Therapy for Eradication of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysisThe Korean Journal of Gastroenterology 2018; 71(1): 31 doi: 10.4166/kjg.2018.71.1.31
42
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised EditionThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020; 20(4): 261 doi: 10.7704/kjhugr.2020.0045
43
Sho Suzuki, Takuji Gotoda, Chika Kusano, Kunio Iwatsuka, Mitsuhiko Moriyama. The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple TherapyAmerican Journal of Gastroenterology 2016; 111(7): 949 doi: 10.1038/ajg.2016.182
44
Anthony O'Connor, Javier P. Gisbert, Colm O'Morain, Spiros Ladas. Treatment of Helicobacter pylori Infection 2015Helicobacter 2015; 20(S1): 54 doi: 10.1111/hel.12258
45
Monjur Ahmed. Digestive System - Recent Advances2020;  doi: 10.5772/intechopen.86652
46
Amrit K. Kamboj, Thomas G. Cotter, Amy S. Oxentenko. Helicobacter pyloriMayo Clinic Proceedings 2017; 92(4): 599 doi: 10.1016/j.mayocp.2016.11.017
47
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020The Korean Journal of Internal Medicine 2021; 36(4): 807 doi: 10.3904/kjim.2020.701
48
Miaomiao Liang, Chengbi Zhu, Peipei Zhao, Xiaohui Zhu, Junwei Shi, Bin Yuan. Comparison of multiple treatment regimens in children with Helicobacter pylori infection: A network meta-analysisFrontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1068809
49
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-Based Guidelines for the Treatment of <i>Helicobacter pylori</i> Infection in Korea 2020Gut and Liver 2021; 15(2): 168 doi: 10.5009/gnl20288
50
Hyuk Lee, Beom Jin Kim, Sang Gyun Kim, Jin Il Kim, Il Ju Choi, Yong Chan Lee, Jae G. Kim, Jae J. Kim. Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trialTrials 2017; 18(1) doi: 10.1186/s13063-017-2281-0
51
Jae Hyun Jung, In Kuk Cho, Chang Hee Lee, Gwan Gyu Song, Ji Hyun Lim. Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for Helicobacter pylori InfectionGut and Liver 2018; 12(2): 165 doi: 10.5009/gnl17177
52
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised EditionThe Korean Journal of Medicine 2021; 96(3): 160 doi: 10.3904/kjm.2021.96.3.160
53
Beom Jin Kim, Hyuk Lee, Yong Chan Lee, Seong Woo Jeon, Gwang Ha Kim, Hyun-Soo Kim, Jae Kyu Sung, Dong Ho Lee, Heung Up Kim, Moo In Park, Il Ju Choi, Soon Man Yoon, Sang Wook Kim, Gwang Ho Baik, Ju Yup Lee, Jin Il Kim, Sang Gyun Kim, Jayoun Kim, Joongyup Lee, Jae Gyu Kim, Jae J. Kim. Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in KoreaGut and Liver 2019; 13(5): 531 doi: 10.5009/gnl19136
54
Nikola Perkovic, Antonio Mestrovic, Josko Bozic, Mirela Pavicic Ivelja, Jonatan Vukovic, Goran Kardum, Zeljko Sundov, Marija Tonkic, Zeljko Puljiz, Katarina Vukojevic, Ante Tonkic. Randomized Clinical Trial Comparing Concomitant and Tailored Therapy for Eradication of Helicobacter pylori InfectionJournal of Personalized Medicine 2021; 11(6): 534 doi: 10.3390/jpm11060534
55
Yonas Tamene, Shefali P Mody, Kaiser O Sadiq, Yogamba M Shivakumar, Eshwar Burra, Kamran Shahid, Tuheen Sankar Nath. Efficacy of Sequential Therapy as the First-Line Treatment in the Eradication of Helicobacter pyloriCureus 2023;  doi: 10.7759/cureus.45593
56
Kee Don Choi. Current Trends ofHelicobacter pyloriEradication in KoreaThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(3): 147 doi: 10.7704/kjhugr.2015.15.3.147
57
Frank J Senatore, Jonathan Wilmot, John W Birk. Helicobacter pyloritreatment: Still a work in progressPostgraduate Medicine 2016; 128(1): 152 doi: 10.1080/00325481.2016.1103194
58
Yoen‐Young Chuah, Deng‐Chyang Wu, Seng‐Kee Chuah, Jyh‐Chin Yang, Tzong‐Hsi Lee, Hong‐Zen Yeh, Chan‐Lin Chen, Yu‐Hwa Liu, Ping‐I Hsu. Real‐world practice and Expectation of Asia‐Pacific physicians and patients in Helicobacter Pylori eradication (REAP‐HP Survey)Helicobacter 2017; 22(3) doi: 10.1111/hel.12380
59
Yan‐Hong Ji, Yan‐Mei Shi, Qian‐Wen Hei, Jin‐Min Sun, Xiao‐Feng Yang, Tao Wu, Da‐Li Sun, Yu‐Xing Qi. Evaluation of guidelines for diagnosis and treatment of Helicobacter pylori infectionHelicobacter 2023; 28(1) doi: 10.1111/hel.12937